Clinically Studied MelaFind®: Medical Imaging Device
An FDA and CE Mark approved innovative software-driven optical imaging and data analysis device designed to be used when a dermatologist chooses to obtain additional information for a decision to biopsy clinically atypical pigmented skin lesions.Click here for important safety information about MelaFind®.
Objectively evaluates clinically atypical pigmented skin lesions (PSLs) up to 2.5mm beneath the surface of the skin and classifies them based on the level of 3-dimensional morphological disorganization.Click here for important safety information about MelaFind®.
FDA and CE Mark Approved MelaFind®
Provides information about the disorganization of clinically atypical pigmented skin lesions.
Dermatologists can choose to use objective, rigorously studied and validated data to incorporate into their complete clinical evaluation and biopsy management decisions.Click here for important safety information about MelaFind®.